Literature DB >> 7537874

An assessment of the antisense properties of RNase H-competent and steric-blocking oligomers.

M A Bonham1, S Brown, A L Boyd, P H Brown, D A Bruckenstein, J C Hanvey, S A Thomson, A Pipe, F Hassman, J E Bisi.   

Abstract

The antisense activity and gene specificity of two classes of oligonucleotides (ONs) were directly compared in a highly controlled assay. One class of ONs has been proposed to act by targeting the degradation of specific RNAs through an RNase H-mediated mechanism and consists of C-5 propynyl pyrimidine phosphorothioate ONs (propyne-S-ON). The second class of antisense agents has been proposed to function by sterically blocking target RNA formation, transport or translation and includes sugar modified (2'-O-allyl) ONs and peptide nucleic acids (PNAs). Using a CV-1 cell based microinjection assay, we targeted antisense agents representing both classes to various cloned sequences localized within the SV40 large T antigen RNA. We determined the propyne-S-ON was the most potent and gene-specific agent of the two classes which likely reflected its ability to allow RNase H cleavage of its target. The PNA oligomer inhibited T Ag expression via an antisense mechanism, but was less effective than the propyne-S-ON; the lack of potency may have been due in part to the PNAs slow kinetics of RNA association. Interestingly, unlike the 2'-O-allyl ON, the antisense activity of the PNA was not restricted to the 5' untranslated region of the T Ag RNA. Based on these findings we conclude that PNAs could be effective antisense agents with additional chemical modification that will lead to more rapid association with their RNA target.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7537874      PMCID: PMC306831          DOI: 10.1093/nar/23.7.1197

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  19 in total

1.  Inhibition of translation initiation by antisense oligonucleotides via an RNase-H independent mechanism.

Authors:  C Boiziau; R Kurfurst; C Cazenave; V Roig; N T Thuong; J J Toulmé
Journal:  Nucleic Acids Res       Date:  1991-03-11       Impact factor: 16.971

2.  NMR solution structure of a peptide nucleic acid complexed with RNA.

Authors:  S C Brown; S A Thomson; J M Veal; D G Davis
Journal:  Science       Date:  1994-08-05       Impact factor: 47.728

3.  Selective elimination of mRNAs in vivo: complementary oligodeoxynucleotides promote RNA degradation by an RNase H-like activity.

Authors:  P Dash; I Lotan; M Knapp; E R Kandel; P Goelet
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

4.  Rate of degradation of [alpha]- and [beta]-oligodeoxynucleotides in Xenopus oocytes. Implications for anti-messenger strategies.

Authors:  C Cazenave; M Chevrier; T T Nguyen; C Hélène
Journal:  Nucleic Acids Res       Date:  1987-12-23       Impact factor: 16.971

5.  Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms.

Authors:  M Y Chiang; H Chan; M A Zounes; S M Freier; W F Lima; C F Bennett
Journal:  J Biol Chem       Date:  1991-09-25       Impact factor: 5.157

Review 6.  Development of antisense therapeutics. Implications for cancer gene therapy.

Authors:  J F Milligan; R J Jones; B C Froehler; M D Matteucci
Journal:  Ann N Y Acad Sci       Date:  1994-05-31       Impact factor: 5.691

7.  Rapid nuclear accumulation of injected oligodeoxyribonucleotides.

Authors:  D J Chin; G A Green; G Zon; F C Szoka; R M Straubinger
Journal:  New Biol       Date:  1990-12

8.  Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines.

Authors:  R W Wagner; M D Matteucci; J G Lewis; A J Gutierrez; C Moulds; B C Froehler
Journal:  Science       Date:  1993-06-04       Impact factor: 47.728

9.  Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters.

Authors:  N M Dean; R McKay; T P Condon; C F Bennett
Journal:  J Biol Chem       Date:  1994-06-10       Impact factor: 5.157

10.  Strand-invasion of duplex DNA by peptide nucleic acid oligomers.

Authors:  N J Peffer; J C Hanvey; J E Bisi; S A Thomson; C F Hassman; S A Noble; L E Babiss
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

View more
  25 in total

Review 1.  Peptide nucleic acids: versatile tools for gene therapy strategies.

Authors:  D A Dean
Journal:  Adv Drug Deliv Rev       Date:  2000-11-15       Impact factor: 15.470

2.  PNA interference mapping demonstrates functional domains in the noncoding RNA Xist.

Authors:  A Beletskii; Y K Hong; J Pehrson; M Egholm; W M Strauss
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

3.  A simple model for gene targeting.

Authors:  T Ratilainen; P Lincoln; B Nordén
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

Review 4.  Therapeutic modulation of endogenous gene function by agents with designed DNA-sequence specificities.

Authors:  Taco G Uil; Hidde J Haisma; Marianne G Rots
Journal:  Nucleic Acids Res       Date:  2003-11-01       Impact factor: 16.971

Review 5.  Insights on chiral, backbone modified peptide nucleic acids: Properties and biological activity.

Authors:  Maria Moccia; Mauro F A Adamo; Michele Saviano
Journal:  Artif DNA PNA XNA       Date:  2016-01-11

6.  Antisense phosphorodiamidate morpholino oligomer length and target position effects on gene-specific inhibition in Escherichia coli.

Authors:  Jesse Deere; Pat Iversen; Bruce L Geller
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

7.  Evaluation of pyrimidine PNA binding to ssDNA targets from nonequilibrium melting experiments.

Authors:  E A Lesnik; L M Risen; D A Driver; M C Griffith; K Sprankle; S M Freier
Journal:  Nucleic Acids Res       Date:  1997-02-01       Impact factor: 16.971

Review 8.  DNA and RNA derivatives to optimize distribution and delivery.

Authors:  Eric Wickstrom
Journal:  Adv Drug Deliv Rev       Date:  2015-04-22       Impact factor: 15.470

9.  Antiproliferative effect in chronic myeloid leukaemia cells by antisense peptide nucleic acids.

Authors:  Valentina Rapozzi; Brigitte E A Burm; Susanna Cogoi; Gijs A van der Marel; Jacques H van Boom; Franco Quadrifoglio; Luigi E Xodo
Journal:  Nucleic Acids Res       Date:  2002-09-01       Impact factor: 16.971

Review 10.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.